0 false false false false false false false false false false false false false true false true true No description of principal activity 2022-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 25,619 1,020 26,639 9,222 3,485 12,707 13,932 16,397 xbrli:pure xbrli:shares iso4217:GBP OC431311 2022-04-01 2023-03-31 OC431311 2023-03-31 OC431311 2022-03-31 OC431311 2021-04-01 2022-03-31 OC431311 2022-03-31 OC431311 2021-03-31 OC431311 core:PlantMachinery 2022-04-01 2023-03-31 OC431311 bus:Director1 2022-04-01 2023-03-31 OC431311 bus:Director2 2022-04-01 2023-03-31 OC431311 core:PlantMachinery 2022-03-31 OC431311 core:PlantMachinery 2023-03-31 OC431311 core:WithinOneYear 2023-03-31 OC431311 core:WithinOneYear 2022-03-31 OC431311 core:AfterOneYear 2023-03-31 OC431311 core:AfterOneYear 2022-03-31 OC431311 core:PlantMachinery 2022-03-31 OC431311 bus:SmallEntities 2022-04-01 2023-03-31 OC431311 bus:AuditExempt-NoAccountantsReport 2022-04-01 2023-03-31 OC431311 bus:SmallCompaniesRegimeForAccounts 2022-04-01 2023-03-31 OC431311 bus:LimitedLiabilityPartnershipLLP 2022-04-01 2023-03-31 OC431311 bus:FullAccounts 2022-04-01 2023-03-31
REGISTERED NUMBER: OC431311
McCready Medical LLP
Filleted Unaudited Financial Statements
31 March 2023
McCready Medical LLP
Statement of Financial Position
31 March 2023
2023
2022
Note
£
£
Fixed assets
Tangible assets
4
13,932
16,397
Current assets
Debtors
5
57,446
57,733
Cash at bank and in hand
39,184
38,177
--------
--------
96,630
95,910
Creditors: amounts falling due within one year
6
28,445
25,767
--------
--------
Net current assets
68,185
70,143
--------
--------
Total assets less current liabilities
82,117
86,540
Creditors: amounts falling due after more than one year
7
26,069
35,338
--------
--------
Net assets
56,048
51,202
--------
--------
Represented by:
Loans and other debts due to members
Other amounts
8
56,048
51,202
--------
--------
Members' other interests
Other reserves
--------
--------
56,048
51,202
--------
--------
Total members' interests
Amounts due from members
(57,446)
(57,733)
Loans and other debts due to members
8
56,048
51,202
Members' other interests
--------
--------
(1,398)
(6,531)
--------
--------
These financial statements have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006 (as applied to LLPs), the statement of comprehensive income has not been delivered.
For the year ending 31 March 2023 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006 (as applied by The Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008) relating to small LLPs.
The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to LLPs) with respect to accounting records and the preparation of financial statements .
McCready Medical LLP
Statement of Financial Position (continued)
31 March 2023
These financial statements were approved by the members and authorised for issue on 31 January 2024 , and are signed on their behalf by:
Dr J McCready
Mrs K M McCready
Designated Member
Designated Member
Registered number: OC431311
McCready Medical LLP
Notes to the Financial Statements
Year ended 31 March 2023
1.
General information
The LLP is registered in England and Wales. The address of the registered office is St Jame's House, Austenwood Common, Gerrards Cross, SL9 8SG, Buckinghamshire.
2.
Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', and the requirements of the Statement of Recommended Practice 'Accounting by Limited Liability Partnerships' issued in December 2018 (SORP 2018).
3.
Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Disclosure exemptions
The entity satisfies the criteria of being a qualifying entity as defined in FRS 102. As such, advantage has been taken of the following disclosure exemptions available under paragraph 1.12 of FRS 102: (a) No cash flow statement has been presented for the LLP. (b) Disclosures in respect of financial instruments have not been presented. (c) No disclosure has been given for the aggregate remuneration of key management personnel.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Members' participation rights
Members' participation rights are the rights of a member against the LLP that arise under the members' agreement (for example, in respect of amounts subscribed or otherwise contributed, remuneration and profits).
Members' participation rights in the earnings or assets of the LLP are analysed between those that are, from the LLP's perspective, either a financial liability or equity, in accordance with Section 22 of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland', and the requirements of the Statement of Recommended Practice 'Accounting by Limited Liability Partnerships'. A member's participation right results in a liability unless the right to any payment is discretionary on the part of the LLP.
Amounts subscribed or otherwise contributed by members, for example members' capital, are classed as equity if the LLP has an unconditional right to refuse payment to members. If the LLP does not have such an unconditional right, such amounts are classified as liabilities.
Where profits are automatically divided as they arise, so the LLP does not have an unconditional right to refuse payment, the amounts arising that are due to members are in the nature of liabilities. They are therefore treated as an expense in the statement of comprehensive income in the relevant year. To the extent that they remain unpaid at the year end, they are shown as liabilities in the statement of financial position.
Conversely, where profits are divided only after a decision by the LLP or its representative, so that the LLP has an unconditional right to refuse payment, such profits are classed as an appropriation of equity rather than as an expense. They are therefore shown as a residual amount available for discretionary division among members in the statement of comprehensive income and are equity appropriations in the statement of financial position.
Other amounts applied to members, for example remuneration paid under an employment contract and interest on capital balances, are treated in the same way as all other divisions of profits, as described above, according to whether the LLP has, in each case, an unconditional right to refuse payment.
All amounts due to members that are classified as liabilities are presented in the statement of financial position within 'Loans and other debts due to members' and are charged to the statement of comprehensive income within 'Members' remuneration charged as an expense'. Amounts due to members that are classified as equity are shown in the statement of financial position within 'Members' other interests'.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
25% reducing balance
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the LLP are assigned to those units.
4.
Tangible assets
Plant and machinery
£
Cost
At 1 April 2022
25,619
Additions
1,020
--------
At 31 March 2023
26,639
--------
Depreciation
At 1 April 2022
9,222
Charge for the year
3,485
--------
At 31 March 2023
12,707
--------
Carrying amount
At 31 March 2023
13,932
--------
At 31 March 2022
16,397
--------
5.
Debtors
2023
2022
£
£
Other debtors
57,446
57,733
--------
--------
6. Creditors: amounts falling due within one year
2023
2022
£
£
Bank loans and overdrafts
10,645
10,607
Other creditors
17,800
15,160
--------
--------
28,445
25,767
--------
--------
7. Creditors: amounts falling due after more than one year
2023
2022
£
£
Bank loans and overdrafts
26,069
35,338
--------
--------
8.
Loans and other debts due to members
2023
2022
£
£
Amounts owed to members in respect of profits
56,048
51,202
--------
--------